Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins

Klesmith, JR; Su, LH; Wu, L; Schrack, IA; Dufort, FJ; Birt, A; Ambrose, C; Hackel, BJ; Lobb, RR; Rennert, PD

Rennert, PD (reprint author), Aleta Biotherapeut, 27 Strathmore Rd, Natick, MA 01760 USA.

MOLECULAR PHARMACEUTICS, 2019; 16 (8): 3544

Abstract

CD19-targeted chimeric antigen receptor (CAR) T-cells (CAR19s) show remarkable efficacy in the treatment of relapsed/refractory acute lymphocytic leuk......

Full Text Link